OpenLegislation

Article 22b F1

United Kingdom

Original text. Later amendments are not shown.

1.

In order to determine the situations in which post-authorisation efficacy studies may be required under Articles 21a and 22a of this Directive, the Commission may adopt, by means of delegated acts in accordance with Article 121a, and subject to the conditions of Articles 121b and 121c, measures supplementing the provisions in Articles 21a and 22a.

2.

When adopting such delegated acts, the Commission shall act in accordance with the provisions of this Directive.

Annotations

Textual amendments

F1

Inserted by Directive 2010/84/EU of the European Parliament and of the Council of 15 December 2010 amending, as regards pharmacovigilance, Directive 2001/83/EC on the Community code relating to medicinal products for human use (Text with EEA relevance).